SCHEMBL4896979

SCHEMBL4896979

C=CCOc1ccccc1[Si](CC)(CC)C1c2cc(Cl)ccc2-c2ccc(Cl)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.41
TSHR P16473 2/20 0.41
GCGR P47871 1/20 0.41
MAPK14 Q16539 1/20 0.41
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ALDH1A1 P00352 1/20 0.32
LIG1 P18858 1/20 0.32
HTR2C P28335 7/20 0.32
HTR2A P28223 6/20 0.32
HTR2B P41595 4/20 0.32
SLC22A1 O15245 1/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
ADRB2 P07550 1/20 0.32
ADRB1 P08588 1/20 0.32
HTR1A P08908 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4889630 0.86 GCGR (0.34) GAATSHRGCGRMAPK14HPGD
SCHEMBL4891829 0.84 TSHR (0.34) GAATSHRGCGRMAPK14NPC1
SCHEMBL4898057 0.84 HPGD (0.32) TSHRNPC1RAB9AHPGDMAPK1
SCHEMBL4894891 0.82 MYB (0.34) GAATSHRGCGRMAPK14HPGD
SCHEMBL4892740 0.82 GAA (0.32) GAATSHR
SCHEMBL4893451 0.80 GAA (0.33) GAATSHRGCGRMAPK14
SCHEMBL4897485 0.80 TSHR (0.34) GAATSHRHSD17B10LMNA
SCHEMBL4896198 0.79 TSHR (0.33) GAATSHRHSD17B10LMNA
SCHEMBL4898035 0.78 GAA (0.33) GAATSHR
SCHEMBL4897799 0.78 TSHR (0.32) GAATSHRHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8084559-B2 Ethylene-vinylcyclohexane copolymers SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-12-27 US disclosed
US-20080161514-A1 Transition Metal Complex, Process For Producing Said Transition Metal Complex, Substituent-Carrying Fluorene Compound, Process For Producing Said Fluorene Compound, Catalyst Component For Olefin Polymerization, Catalyst For Olefin Polymerization, and Process For Producing Olefin Polymer SUMITOMO CHEMICAL COMPANY, LIMTIED (JP) 2008-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161514-A1 Transition Metal Complex, Process For Producing Said Transition Metal Complex, Substituent-Carrying Fluorene Compound, Process For Producing Said Fluorene Compound, Catalyst Component For Olefin Polymerization, Catalyst For Olefin Polymerization, and Process For Producing Olefin Polymer AOC2, ACSL1, ACSL3 GAA 3594/4885TSHR 3725/4885GCGR 4754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.